Galera Therapeutics

Logo GlobeNewswire
SciencePress Release2023-03-23 20:01:00
Phase 2 trials of VTX958 (TYK2 inhibitor) are ongoing in plaque psoriasis, Crohns disease and psoriatic arthritis, with topline Phase 2 data in plaque...

Logo GlobeNewswire
SciencePress Release2023-03-23 12:30:00
BASKING RIDGE, N.J., March 23, 2023 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (Lisata or the Company), a clinical-stage pharmaceutical...

Logo Benzinga
Business / FinanceBy Vandana Singh2023-03-23 14:35:33
The FDA approved Cidara Therapeutics Inc's CDTX antifungal Rezzayo (rezafungin) under priority review for treating candidemia and invasive candidiasis in...

Logo PR Newswire
HealthPress Release2023-03-23 13:00:00
Enhanced Technology Optimizes Triage, with Direct Physician Access to Improve Outcomes and Reduce Costs CHICAGO, March 23, 2023 /PRNewswire/ -- Vivante...

Logo PR Newswire
HealthPress Release2023-03-23 13:23:00
NEW YORK, March 23, 2023 /PRNewswire/ --The Lupus Research Alliance (LRA) today announced the recipients of the newest Lupus Innovation Award (LIA) grants....

Logo NewsFileCorp
Press Release2023-03-23 08:00:00
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - March 23, 2023) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or...

Logo PR Newswire
HealthPress Release2023-03-23 17:50:00
NEW YORK, March 23, 2023 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. (Aquavit), a biotechnology company focused on the development of a first-of-its-kind...

Logo Benzinga
Business / FinanceBy Business Wire2023-03-23 20:01:00
Better Therapeutics, Inc. BTTX, a prescription digital therapeutics (PDT) company developing a clinically validated, software-based novel form of cognitive...

Logo PR Newswire
HealthPress Release2023-03-23 13:00:00
JERSEY CITY, N.J., March 23, 2023 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced it has completed enrollment for the global,...

Logo PR Newswire
HealthPress Release2023-03-23 15:28:00
SHANGHAI, March 23, 2023 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the European Medicines Agency (EMA) has validated the...

Logo GlobeNewswire
SciencePress Release2023-03-23 12:00:00
BERKELEY, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- Valitor, a biotechnology company engineering better medicines to conquer drug limitations, today...

Logo EIN Presswire
Aurum Group The fund will finance the rehabilitation of injured Ukrainian children under the age of 15 KYIV, UKRAINE, March 23, 2023/ EINPresswire.com / --...

Logo GlobeNewswire
SciencePress Release2023-03-23 20:05:00
On track to complete enrollment in Phase 2/3 LIFT-AD trial of fosgonimeton for mild-to-moderate Alzheimers disease in mid-2023 with topline data in early...

Logo GlobeNewswire
SciencePress Release2023-03-22 12:00:00
BRIDGEWATER, N.J., March 22, 2023 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (VYNE or the Company), a clinical-stage biopharmaceutical company...

Logo PR Newswire
CHICAGO, March 23, 2023 /PRNewswire/ -- Waud Capital Partners (Waud Capital), in partnership with experienced healthcare executives Bales Nelson and Allen...

Logo EIN Presswire
Drugs For Hormonal Replacement Therapy Global Market Report 2023 - Market Size, Trends, And Global Forecast 2023-2032 The Business Research Company's Drugs...

Logo Benzinga
Business / FinanceBy Business Wire2023-03-23 20:01:00
$71.0 million cash balance at the end of 2022 expected to provide cash runway into 2025 Acquired Bioniz Therapeutics, including two first-in-class...

Logo EIN Presswire
AU409 trial to be conducted by Dr. Anthony El-Khoueiry at the USC Norris Comprehensive Cancer Center, University of Southern California PALO ALTO,...

Logo GlobeNewswire
SciencePress Release2023-03-23 20:05:00
SOUTH SAN FRANCISCO, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- DICE Therapeutics, Inc. (Nasdaq: DICE) (DICE or the Company), a biopharmaceutical company...

Logo GlobeNewswire
SciencePress Release2023-03-23 21:00:00
Daix (France), Long Island City (New York, United States), March 23, 2023 Inventiva (Euronext Paris and Nasdaq: IVA) (the Company), a clinical-stage...